VERTEX PHARMACEUTICALS INC / MA 8-K

What Happened
Vertex Pharmaceuticals Inc. announced consolidated financial results for the three months ended March 31, 2026 by issuing a press release on May 4, 2026. The press release reporting the company’s quarterly results is attached to the Form 8-K as Exhibit 99.1 and is incorporated by reference in the filing.

Key Details

• Press release announcing Q1 2026 results issued on May 4, 2026.
• Results cover the three months ended March 31, 2026 (quarterly results / earnings period).
• The press release is included as Exhibit 99.1 to the Form 8-K; the cover page XBRL is in Exhibit 104.
• The company states Exhibit 99.1 is furnished (not “filed”) for Section 18 purposes and is not automatically incorporated by reference into other registration statements.

Why It Matters
This 8-K signals that Vertex has released its latest quarterly earnings and related financial metrics (revenue, profit, cash flow, etc.), which are material to investors evaluating the company's near-term performance. Retail investors should review the attached press release for specific figures, trends, and any commentary on guidance or operational developments to assess potential impacts on the stock and investment thesis.